Compounds > celastrol
Page last updated: 2024-09-03

celastrol and Bone Neoplasms

celastrol has been researched along with Bone Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; He, B; Liu, H; Ou, Y; Tao, Y; Yin, H; Yu, H; Zhao, Z; Zhong, S1
Guo, Y; He, P; Huang, S; Li, J; Li, S; Peng, X; Tang, Y; Wa, Q; Xu, D; Zhang, X; Zuo, J1
Dai, M; Fu, C; Guo, R; Liu, H; Nie, T; Wang, Q; Yu, X; Zhang, B; Zhou, X; Zou, F1
He, P; Huang, S; Li, J; Peng, X; Tang, Y; Xu, D1
Huang, S; Kuchta, K; Li, J; Lin, Z; Pan, T; Peng, X; Tang, Y; Wang, X; Xiang, Y; Xu, J; Zhu, Y1

Other Studies

5 other study(ies) available for celastrol and Bone Neoplasms

ArticleYear
Effect and mechanisms of celastrol on the apoptosis of HOS osteosarcoma cells.
    Oncology reports, 2018, Volume: 40, Issue:4

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Biomarkers, Tumor; Bone Neoplasms; Cell Proliferation; eIF-2 Kinase; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Mitochondria; Osteosarcoma; Pentacyclic Triterpenes; Reactive Oxygen Species; Signal Transduction; Triterpenes; Tumor Cells, Cultured

2018
Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
    Oncology reports, 2015, Volume: 33, Issue:3

    Topics: Antineoplastic Agents; Argonaute Proteins; Bone Neoplasms; Cadherins; Cell Hypoxia; Cell Proliferation; Cell Transformation, Neoplastic; Epithelial-Mesenchymal Transition; Fibronectins; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Hyaluronan Receptors; Hypoxia-Inducible Factor 1, alpha Subunit; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Neoplasm Invasiveness; Neoplastic Stem Cells; Octamer Transcription Factor-3; Pentacyclic Triterpenes; Prostatic Neoplasms; Spheroids, Cellular; Transcription Factors; Triterpenes; Tumor Cells, Cultured; Vimentin; Zinc Finger E-box-Binding Homeobox 1

2015
Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway.
    Oncology reports, 2015, Volume: 34, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flow Cytometry; Humans; Membrane Potential, Mitochondrial; Mitochondria; Osteosarcoma; Pentacyclic Triterpenes; Triterpenes

2015
Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 37, Issue:1

    Topics: AC133 Antigen; Aged; Animals; Antigens, CD; Bone Marrow Cells; Bone Neoplasms; Cell Line, Tumor; Endothelial Cells; Glycoproteins; Humans; Hyaluronan Receptors; Male; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Middle Aged; Neoplastic Stem Cells; Neovascularization, Pathologic; Nitric Oxide Synthase Type III; Pentacyclic Triterpenes; Peptides; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Triterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2015
Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis.
    Prostate cancer and prostatic diseases, 2017, Volume: 20, Issue:2

    Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Male; Medicine, Chinese Traditional; Neoplasm Invasiveness; Neoplasm Metastasis; Pentacyclic Triterpenes; Prostatic Neoplasms; Triterpenes; Vascular Endothelial Growth Factor A

2017